top of page
BULLOUS PEMPHIGOID
CURRENTLY ENROLLING TRIALS
A Randomized, Part A Partial Blinded and Part B Double Blinded, Placebo-Controlled 24-Week Clinical Study to Evaluate the Efficacy and Safety of Nomacopan Therapy in Adult Patients with Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP)
Open for participants age 18 to 89 with a clinical diagnosis of Bullous Pemphigoid.
Requirements:
-
Ability to travel to site visits.
Further inclusion/exclusion criteria apply. If you think you may qualify, please contact us.
Don't qualify for any of our trials?
UPCOMING CLINICAL TRIALS
We begin new trials often. If you do not qualify for our current studies, please leave your information, and we'll keep you updated of any upcoming trials that may be right for you.
bottom of page